Akhil Srivastava

Statistics

Publications

Citations

886

H-Index

Active since

2011

Affiliations

University of Oklahoma Health Sciences Center(Current)

University of Hawaiʻi at Mānoa

Korea Research Institute of Bioscience and Biotechnology

Joint Genome Institute

Akhil Srivastava is an author at University of Oklahoma Health Sciences Center specializing in oncology, plant-pathogen interactions, and plant pathogenesis.

ORCID

Publications per year

2011–2024

Publications

Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells

Akhil Srivastava, Narsireddy Amreddy, Anish Babu et al. · Scientific Reports · 2016 · 189 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment

Narsireddy Amreddy, Anish Babu, Janani Panneerselvam et al. · Nanomedicine Nanotechnology Biology and Medicine · 2017 · 137 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16

Transcription Factor Amr1 Induces Melanin Biosynthesis and Suppresses Virulence in Alternaria brassicicola

Yangrae Cho, Akhil Srivastava, Robin A. Ohm et al. · PLoS Pathogens · 2012 · 109 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients

Akhil Srivastava, Katherine Moxley, R. Ruskin et al. · The AAPS Journal · 2018 · 105 citations

Medicine, Molecular Biology, Oncology +14

Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth <i>In Vitro</i> and <i>In Vivo</i> By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR

Ranganayaki Muralidharan, Anish Babu, Narsireddy Amreddy et al. · Molecular Cancer Therapeutics · 2017 · 66 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

1–5 of 14